Core Tip: Sales of Novo Nordisk's Wegovy pill were kr5.39 billion, up 53% from Q2 and above the kr4.62 billion forecast in the company-compiled consensus.
Sales of Novo Nordisk's Wegovy pill were kr5.39 billion, up 53% from Q2 and above the kr4.62 billion forecast in the company-compiled consensus.